Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CVRX | Common Stock | Conversion of derivative security | +1.55M | 1.55M | Jul 2, 2021 | See Footnote | F1, F2 | |||
transaction | CVRX | Common Stock | Purchase | $4.95M | +275K | +17.7% | $18.00 | 1.83M | Jul 2, 2021 | See Footnote | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CVRX | Series G Preferred Stock | Conversion of derivative security | $0 | -24.6M | -100% | $0.00* | 0 | Jul 2, 2021 | Common Stock | 1.55M | See Footnote | F1, F2, F3 |
Id | Content |
---|---|
F1 | Upon the closing of the Issuer's initial public offering, each share of Series G Convertible Preferred Stock automatically converted into shares of common stock at a rate of 1-for-0.0632143218. |
F2 | These shares are held directly by Cooperatieve Gilde Healthcare IV U.A. ("Gilde IV"). The Reporting Person is a partner of Gilde IV and may be deemed to share voting and dispositive over the shares held by Gilde IV. The Reporting Person disclaims beneficial ownership of all applicable shares except to the extent of his actual pecuniary interest in such shares. |
F3 | Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of common stock at the then-appliable conversion rate for no additional consideration (subject to the payment of cash in lieu of any fractional shares). The conversion rates reported reflect the conversion ratios under the Issuer's certificate of incorporation, adjusted to give effect to the previously effected 1-for-39.548 reverse stock split of the common stock. |